These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21040208)

  • 21. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
    Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
    Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles.
    Virro MR; Larson-Cook KL; Evenson DP
    Fertil Steril; 2004 May; 81(5):1289-95. PubMed ID: 15136092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure.
    Van Landuyt L; De Vos A; Joris H; Verheyen G; Devroey P; Van Steirteghem A
    Fertil Steril; 2005 May; 83(5):1397-403. PubMed ID: 15866575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of fertilization methods and sperm sources on the developmental capacity of surplus embryos].
    Xu ZP; Sun HX; Hu YL; Zhang NY; Wang B
    Zhonghua Nan Ke Xue; 2009 Oct; 15(10):901-5. PubMed ID: 20112738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
    Bjercke S; Tanbo T; Abyholm T; Omland A; Opøien HK; Fedorcsak P
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome.
    Dayal MB; Gindoff PR; Sarhan A; Dubey A; Peak D; Frankfurter D
    Fertil Steril; 2009 Jan; 91(1):101-5. PubMed ID: 18249397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved in vitro fertilization embryo quality and pregnancy rates with intracytoplasmic sperm injection of sperm from fresh testicular biopsy samples vs. frozen biopsy samples.
    Aoki VW; Wilcox AL; Thorp C; Hamilton BD; Carrell DT
    Fertil Steril; 2004 Dec; 82(6):1532-5. PubMed ID: 15589855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of in vitro fertilization versus intracytoplasmic sperm injection in extremely low oocyte retrieval cycles.
    Ou YC; Lan KC; Huang FJ; Kung FT; Lan TH; Chang SY
    Fertil Steril; 2010 Jan; 93(1):96-100. PubMed ID: 19108823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An initial low response predicts poor outcome in in vitro fertilization/intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles.
    Veleva Z; Järvelä IY; Nuojua-Huttunen S; Martikainen H; Tapanainen JS
    Fertil Steril; 2005 May; 83(5):1384-90. PubMed ID: 15866573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?
    Azem F; Tal G; Lessing JB; Malcov M; Ben-Yosef D; Almog B; Amit A
    Gynecol Endocrinol; 2008 Jul; 24(7):368-72. PubMed ID: 18645708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone levels on oocyte retrieval day can predict the quantity of viable embryos but not pregnancy outcome of intracytoplasmic sperm injection.
    Niu Z; Feng Y; Zhang A; Sun Y; Zhang H
    Gynecol Endocrinol; 2008 Aug; 24(8):452-8. PubMed ID: 18850383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential growth of human embryos in vitro: role of reactive oxygen species.
    Bedaiwy MA; Falcone T; Mohamed MS; Aleem AA; Sharma RK; Worley SE; Thornton J; Agarwal A
    Fertil Steril; 2004 Sep; 82(3):593-600. PubMed ID: 15374701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: Randomised, controlled, multi-centre trial.
    Abate A; Nazzaro A; Salerno A; Marzano F; Pavone Cossut MR; Perino M
    Gynecol Endocrinol; 2009 Aug; 25(8):479-84. PubMed ID: 19572228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GnRH agonist and GnRH antagonist in intracytoplasmic injection cycles.
    Rashid MR; Ong FB; Omar MH; Ng SP; Nurshaireen A; Sharifah-Teh NS; Fazilah AH; Zamzarina MA
    Med J Malaysia; 2008 Jun; 63(2):113-7. PubMed ID: 18942295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment option for unexplained primary infertility following failed intrauterine insemination].
    Ding W; Liu J; Qian Y; Yang N; Mao Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):737-9, 742. PubMed ID: 15562784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of short and long ovulation induction protocols used in ART applications according to the ovarian response and outcome of pregnancy.
    Tavmergen E; Göker EN; Sendag F; Sendag H; Levi R
    Arch Gynecol Obstet; 2002 Jan; 266(1):5-11. PubMed ID: 11998967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.